COVID-19 mRNA vaccine

9 November 2022  News release (WHO) WHO’s Global Vaccine Market Report 2022, shows that inequitable distribution is not unique to COVID-19 vaccines, with poorer countries consistently struggling to access vaccines that are…

Overview Ensuring communities have access to lifesaving public health information from trusted sources and are not misled by misinformation is essential to ending the COVID-19 pandemic. This toolkit aims to…

HIGHLIGHTS The COVAX Facility has notified participating economies that deliveries of doses from the Serum Institute of India (SII) will be delayed in March and April. Delays in securing supplies…

As of 17 March 2021, more than 120 million cases of COVID-19 infections, with more than 2 million deaths, had been reported globally.  Vaccination remains a critical tool to help…

The World Health Organization (WHO) and Chubb Limited (NYSE: CB), through ESIS Inc., a Chubb company, signed an agreement on behalf of the COVAX Facility on 17 February 2021 for…

Declaration We must accelerate vaccine equity for all health workers – now Health and care workers have been at the forefront of the pandemic response: often under protected and over…

The Ministry of Health & Population has released Frequently Asked Questions (FAQs) on the COVID-19 vaccine. The COVID-19 vaccination campaign will be launched from Jan 27, 2021 in Nepal.

The Department of Drug Administration (DDA) has decided to approve ‘COVISHIELD’ COVID-19 vaccine for emergency use in Nepal. DDA provided the conditional permission for emergency authorisation of COVISHEILD vaccine against…

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access. The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine…